Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07058467 · ClinicalTrials.gov registry record · NA
Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation
A NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Anterior Cruciate Ligament (ACL) Tear, sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07058467: Recruiting NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Anterior Cruciate Ligament (ACL) Tear, sponsored by University of North Carolina, Chapel Hill.
NCT07058467 is a NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Anterior Cruciate Ligament (ACL) Tear that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants, below the 40-participant average among 4 other Anterior Cruciate Ligament Reconstruction Rehabilitation trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07058467, a NA study of Anterior Cruciate Ligament Reconstruction Rehabilitation and Anterior Cruciate Ligament (ACL) Tear, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate whether knee joint manipulation can improve neurocognitive and neuromuscular performance in individuals with a history of anterior cruciate ligament reconstruction (ACLR). Recruitment will consist of 30 participants aged 18-35 who are 4 months to 5 years post-ACLR and demonstrate measurable reaction time delays. Using a within-subject pre-post design, participants will complete a battery of neurocognitive and neuromuscular assessments, including visuomotor reaction time and dual-task hop testing, before and after knee joint manipulation(s). The main questions the investigators aim to address are: Aim 1: Evaluate the feasibility, acceptability, and applicability of integrating knee joint manipulation into post-ACLR rehabilitation using the Implementation and Outcomes Framework. Aim 2: Determine preliminary efficacy of knee joint manipulation on neurocognitive performance in individuals with ACLR.
Conditions Studied
Interventions
- OTHER Joint Manipulation
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT07058467 shows while recruiting
NCT07058467 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 40-participant average among 4 other Anterior Cruciate Ligament Reconstruction Rehabilitation trials with a reported enrollment target (25% lower).
The record links to 2 conditions, with Anterior Cruciate Ligament Reconstruction Rehabilitation appearing as the primary indexed condition, and to 1 intervention - of which Joint Manipulation is the first listed.
NCT07058467 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07058467 about?
NCT07058467 is a clinical study titled "Anterior Cruciate Ligaments: Studying Updates in neuroCognition After Knee Manipulation". This study will investigate whether knee joint manipulation can improve neurocognitive and neuromuscular performance in individuals with a history of anterior cruciate ligament reconstruction (ACLR). Recruitment will consist of 30 participants aged 18-35 who are 4 months to 5 years post-ACLR and dem...
What is the current status of trial NCT07058467?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-08-01. Estimated completion is 2026-05-31.
What conditions does trial NCT07058467 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation, Anterior Cruciate Ligament (ACL) Tear.
What interventions are being tested in trial NCT07058467?
The interventions under investigation include: Joint Manipulation (OTHER).
Who is sponsoring clinical trial NCT07058467?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07058467 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Reconstruction Rehabilitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ACL Reconstruction Rehabilitation With Exercise and Psychological Support
RECRUITING · NA
-
Evaluation of Home-based Telerehabilitation Platform to Augment Orthopedic Rehabilitation
RECRUITING · NA
-
BFRT MPFL and ACL Reconstruction Rehab
COMPLETED · NA
-
Determining the Effects of Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After ACL Reconstruction
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI